Search | Clinical Trials Finder

The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 7:28 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 3241–3264 of 22,019 matching trials from the local directory fallback.

Filters: Recruiting Clear all

Conditions: Epilepsy, Epilepsy, Temporal Lobe, Partial Epilepsy, Seizures
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 8 Years to 110 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2037
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diabetes Complications, Diabetic Retinopathy
Interventions: Generation of inducible pluripotent stem cells; Biological
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 21 Years to 98 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Depression
Interventions: Growth Mindset; Behavioral
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 11 Years to 25 Years
Enrollment: 4,100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2027
U.S. locations: 3
States / cities: Los Angeles, California • Denver, Colorado • Bethesda, Maryland

Conditions: Ciliary Body Medulloepithelioma, Cystic Nephroma, DICER1 Syndrome, Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma of Cervix, Embryonal Rhabdomyosarcoma of Uterus (Diagnosis), Embryonal Rhabdomyosarcoma of Vagina (Diagnosis), Gynandroblastoma, Intracranial Sarcoma, Nasal Chondromesenchymal Hamartoma, Neuroblastoma, Nodular Hyperplasia of Thyroid, Ovarian Sarcoma, Pineoblastoma, Pituitary Cancer, Pleuropulmonary Blastoma, Renal Sarcoma, Sertoli-Leydig Cell Tumor, Thyroid Carcinoma, Wilms Tumor
Interventions: Not listed
Lead sponsor: Children's Hospitals and Clinics of Minnesota; Other
Eligibility: 0 Minutes to 100 Years
Enrollment: 3,400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2036
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Diabetes
Interventions: Not listed
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cushing Disease, Cushing Syndrome, Cushing's Disease
Interventions: Barratt's Impulsivity Scale (BIS), Beck Depression Inventory (BDI), Cushing's QoL (Quality of Life Questionnaire), Hospital Anxiety and Depression Scale (HADS), Nottingham Health Profile (NHP), Perceived Stress Scale (PSS), Sensitivity to Reinforcement of Addictive and other Primary Rewards (STRAP-R) food variant, State Food Craving Questionnaire-State (FCQ-S), State-Trait Anxiety Inventory (STAI), Trait Food Craving Questionnaire-Trait (FCQ-T), Visual Analogue Scale (VAS); Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 14 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Neuroendocrine Neoplasms, Neuroendocrine Tumors, Paraganglioma, Pheochromocytoma
Interventions: Ga-68-DOTATATE, Lu-177-DOTATATE; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2033
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Diffuse Midline Glioma, H3 K27M-Mutant
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Not listed
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2047
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Cellular Immunotherapy, Adoptive, Genetic Therapy, Hematopoietic Stem Cell Transplantation, Tissue Donors
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 4 Years to 120 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2050
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diseases, Stomatognatic, Tooth, Tooth Diseases, Tooth Impaction
Interventions: Not listed
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: 16 Years to 50 Years
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Non-small Cell Lung Cancer (NSCLC)
Interventions: Vaccine + PolyICLC; Biological
Lead sponsor: Olivera Finn; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2032
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Hodgkin Disease, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Multiple Myeloma
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 1,295 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Healthy Subjects, Healthy Volunteer, Immunosuppression, Periodontal Disease
Interventions: Not listed
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: 7 Years to 100 Years
Enrollment: 700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Amenorrhea, Genetic Disorder, Hypogonadism, Infertility
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 6 Weeks to 120 Years
Enrollment: 850 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2012
U.S. locations: 2
States / cities: Bethesda, Maryland • Research Triangle Park, North Carolina

Conditions: Age-Related Macular Degeneration, Diabetic Retinopathy, Retinal Disease, Retinal Vein Occlusion, Von Hippel-Lindau Syndrome
Interventions: Not listed
Lead sponsor: National Eye Institute (NEI); NIH
Eligibility: 2 Years to 120 Years
Enrollment: 650 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Paralysis, Paraplegia, Spinal Cord Injury, Tetraplegia
Interventions: IRS-8 (8-Channel implanted stimulator-telemeter); Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: HHV-8, KSHV, KSHV Inflammatory Cytokine Syndrome (KICS)
Interventions: Cohort 1, Liposomal Doxorubicin, Rituximab, Standard Therapies, Valganiclovir, Zidovudine; Other · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2028
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Epilepsy, Epilepsy, Temporal Lobe, Partial Epilepsy
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 8 Years to 99 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Charcot Marie Tooth Disease
Interventions: Not listed
Lead sponsor: Michael Shy; Other
Eligibility: Not listed
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2030
U.S. locations: 18
States / cities: Los Angeles, California • Palo Alto, California • Aurora, Colorado + 14 more

Conditions: Asthma, Atherosclerosis, Cancer, Insulin Resistance, Metabolic Syndrome
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 725 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2012
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Autoimmune Disease, Glomerular Disease, Membranous Glomerulonephritis, Nephrotic Syndrome, Proteinuria
Interventions: Oral Cyclosporine, Rituximab Infusion; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2027
U.S. locations: 2
States / cities: Bethesda, Maryland

Conditions: Sickle Cell Anemia, Sickle Cell Disease, Sickle Cell Trait
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Familial Tumoral Calcinosis, Osteomalacia, Tumor Induced Osteomalcia
Interventions: Not listed
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: 1 Day to 100 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Brain Disease, Cerebrovascular Accident, Cerebrovascular Disorder, Ischemic Attack, Transient, Vascular Diseases
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 4,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2001
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Bethesda, Maryland

Search by objective public record fields.

Investigating Epilepsy: Screening and Evaluation

Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy

Characterization and Treatment of Adolescent Depression

International PPB/DICER1 Registry

Taste Bud-Derived Stem Cells in Humans

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository

Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy

Oral Specimen and Data Acquisition Study of Subjects Requiring Third Molar Removal

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Tissue Collection for Studies of Lymph Cancer

Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)

Inherited Reproductive Disorders

National Eye Institute Biorepository for Retinal Diseases

A Neuroprosthesis for Seated Posture and Balance

Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

Surgery as a Treatment for Medically Intractable Epilepsy

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

Blood Sampling for Research Related to Sickle Cell Disease

A Natural History Study of Bone and Mineral Disorders

Natural History of Stroke: Cause and Development